UMIN-CTR Clinical Trial

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000032348
Receipt No. R000036895
Official scientific title of the study Outcomes of Phototherapeutic Keratectomy Using Anti CI program.
Date of disclosure of the study information 2018/04/23
Last modified on 2018/04/23 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Outcomes of Phototherapeutic Keratectomy Using Anti CI program.
Title of the study (Brief title) Outcomes of Phototherapeutic Keratectomy Using Photorefractive Keratectomy Mode.
Region
Japan

Condition
Condition band keratopathy and granular corneal dystrophy
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the outcomes of phototherapeutic keratectomy (PTK) using anti-central island (CI) program and to compare visual acuity and the rate of CI after PTK with and without CI program.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Postoperative Visial acurity
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
38 years-old <=
Age-upper limit
92 years-old >=
Gender Male and Female
Key inclusion criteria Patients who had PTK for corneal degeneration at Kitasato University Hospital
Key exclusion criteria Patients with other corneal diseases, active uveitis, glaucoma, ocular floor disease
Target sample size 100

Research contact person
Name of lead principal investigator Kazutaka Kamiya
Organization Kitasato University Hospital
Division name Ophthalmology
Address 1-15-1 Kitasato Minami-ku Sagamihara-shi
TEL 0427788111
Email ads00133@gmail.com

Public contact
Name of contact person Masahide Takahashi
Organization Kitasato University Hospital
Division name Ophthalmology
Address 1-15-1 Kitasato Minami-ku Sagamihara-shi
TEL 0427788111
Homepage URL
Email zavide96@gmail.com

Sponsor
Institute Kitasato University Hospital
Institute
Department

Funding Source
Organization Kitasato University Hospital
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 04 Month 23 Day

Progress
Recruitment status Main results already published
Date of protocol fixation
2018 Year 04 Month 22 Day
Anticipated trial start date
2018 Year 04 Month 22 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Partially published
URL releasing results
Results
Other related information The use of the anti-CI program for PTK with the VISX Star S4 excimer laser system significantly decrease the rate of CI formation, in association with the improvement of visual acuity.

Management information
Registered date
2018 Year 04 Month 23 Day
Last modified on
2018 Year 04 Month 23 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036895